StockMarketWire.com - ANGLE (AGL) (AGL.L) [LON.AGL] will be presenting their plans for development and growth at the first ever investor evening to be organised by Shares Magazine in Manchester.

These events, which are sponsored by AJ Bell Youinvest, provide the opportunity for companies to meet existing investors and those looking for new investment opportunities.

The presentation from ANGLE, a specialist medtech company listed on the London Stock Exchange AIM market, will be given by its chief executive officer, Andrew Newland, and the finance director, Ian Griffiths.

The company's lead product is the Parsortix micro-fluidic cell separation device, which can capture very rare circulating tumour cells (CTCs) in cancer patient blood.

This can assist with early detection of cancer, personalised treatment, the monitoring of patients during treatment and post-treatment monitoring of cancer patients in remission.

The venue for the Manchester investor evening is the members suite at Emirates Old Trafford, the home of Lancashire County Cricket Club, and it will take place on March 31. The presentations will begin at 6.30 p.m.

The other companies taking part are Alkane Energy (ALK) (ALK.L), [LON.ALK], Valirx (VAL), (VAL.L) [VAL.LON] and Vipera (VIP), (VIP.L), {LON.VIP].

Investors have the opportunity to register now for free at www.sharesmagazine.co.uk/events


At 10:25am: [LON:AGL] ANGLE PLC share price was -0.5p at 76.5p



Story provided by StockMarketWire.com